According to a new market research report published by Global Market Estimates, the Global Transcranial Magnetic Stimulators (TMS) Market is projected to grow at a CAGR value of 8.5% from 2022 to 2027. Rising prevalence of neurological diseases among the proportion of older people, as well as the quick emergence of non-invasive, electrostatic pulse-administered therapy for neurological disorders. Furthermore, rising anxiety and depression rates, particularly during the coronavirus pandemic, will contribute to the worldwide industry's growth over the forecast period.

Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Transcranial Magnetic Stimulators (TMS) Market - Forecast to 2027" https://www.globalmarketestimates.com/market-report/transcranial-magnetic-stimulators-tms-market-3707

By Application (Tinnitus, Alzheimer, Parkinson’s Disease, Psychiatric Disorders, Stroke, and Others) By Type (Single-pulse Transcranial Magnetic Stimulators and Repetitive Pulse Transcranial Magnetic Stimulators), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa), Company Market Share Analysis, and Competitor Analysis

 Key Market Insights

·         As per the application outlook, Alzheimer’s disease segment is expected to grow the fastest in the market from 2022 to 2027

·         The repetitive pulse transcranial magnetic stimulators segment is expected to grow the fastest in the market from 2022 to 2027 as per the type outlook

·         The rising acceptability of the treatment to deal with patients who may not respond to psychoanalysis or antidepressant medication is driving the market growth during the forecast period

·         The quick emergence of non-invasive, electrostatic pulse-administered therapy for neurological disorders is also expected to drive the demand for TMS during the forecast period

·         Axium Robotics, Brainbox, TeleMag Health, Brainsway, Dr. Langer Medical, eNeura, MAG & More GmbH, The Magstim Company Limited, MagVenture, Neuronetics, Neurosoft (OPAP Investment), Nexstim, Remed, Yiruide, TMS Neuro Solutions, neuroCare Group GmbH, EB Neuro, among others are the key players in the global transcranial magnetic stimulators (TMS) market.

Application Outlook (Revenue, USD Billion, 2022 - 2027)

·         Tinnitus

·         Alzheimer

·         Parkinson’s Disease

·         Psychiatric Disorders

·         Stroke

·         Others

Type Outlook (Revenue, USD Billion, 2022 - 2027)

·         Single-pulse Transcranial Magnetic Stimulators

·         Repetitive Pulse Transcranial Magnetic Stimulators

Regional Outlook (Revenue, USD Billion, 2022-2027)

North America                                                                                 

• The U.S.
• Canada
• Mexico

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC

Central & South America

• Brazil
• Argentina
• Rest of CSA

Middle East & Africa

• Saudi Arabia
• UAE
• Rest of MEA

 

Contact: Yash Jain

Email address: yash.jain@globalmarketestimates.com

Phone Number: +16026667238